Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Assisted Reproduction and Genetics
Erschienen in: Journal of Assisted Reproduction and Genetics 6/2006

01.06.2006 | Original Paper

Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population

verfasst von: Aykut Bayrak, Djana Harp, Peyman Saadat, Eliran Mor, Richard J. Paulson

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Purpose: The purpose of this study was to determine the recurrence rate of hydrosalpinges after cuff neosalpingostomy in poor prognosis candidates.
Methods: Forty consecutive patients with hydrosalpinx treated with cuff neosalpingostomy were included. Main outcome measures were recurrence rate of hydrosalpinx after cuff neosalpingostomy, intrauterine and ectopic pregnancy rates.
Results: Intraoperatively, the mean size of the hydrosalpinx was 1.9±0.7 cm, and 77% of patients had evidence of pelvic adhesions. Recurrence of hydrosalpinx, whether unilateral or bilateral was 70% (28/40) per patient. Intrauterine and ectopic pregnancy rates were 5% (2/40) and 2.5% (1/40), with a total pregnancy rate of 7.5% (3/40).
Conclusions: Most patients experience recurrence of hydrosalpinx after cuff neosalpingostomy, thus requiring additional surgery such as salpingectomy prior to in vitro fertilization (IVF). In a poor prognosis population, salpingectomy should be considered as the primary treatment for hydrosalpinx prior to IVF.
Literatur
1.
Bahamondes L, Bueno JGR, Hardy E, Vera S, Pimental E, Ramos M. Identification of main risk factors of tubal infertility. Fertil Steril 1984;61:478–82
2.
Katz E, Akman MA, Damewood MD, Garcia JE. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in vitro fertilization. Fertil Steril 1996;66:122–5PubMed
3.
Kassabji M, Sims JA, Butler L, Muasher SJ. Reduced pregnancy outcome in patients with unilateral or bilateral hydrosalpinx after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol 1994;56:129–32PubMedCrossRef
4.
Strandell A, Waldenstrom U, Nilsson L, Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod 1994;9:861–3PubMed
5.
Mukherjee T, Copperman AB, McCaffrey C, Cook CA, Bustilo M, Obasaju MF. Hydrosalpinx fluid has embryotoxic affects on murine embryogenesis: a case for prophylactic salpingectomy. Fertil Steril 1996;66:851–3PubMed
6.
Beyler SA, James KP, Fritz MA, Meyer WR. Hydrosalpingeal fluid inhibits in vitro embryonic development in a murine model. Hum Reprod 1997;12:2724–8PubMedCrossRef
7.
Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE. et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod 1997;12:1393–8
8.
Strandell A, Lindhard A, Waldenstrom U, Thornburn J, Janson PO, Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999;14:2762–9PubMedCrossRef
9.
Surrey ES, Schoolcraft WB. Laparoscopic management of hydrosalpinges before in vitro fertilization-embryo transfer: salpingectomy versus proximal tubal occlusion. Fertil Steril 2001;75:612–7PubMedCrossRef
10.
Murray DL, Sagoskin AW, Widra EA, Levy MJ. The adverse effect of hydrosalpinges on in vitro fertilization pregnancy rates and the benefit of surgical correction. Fertil Steril 1998;69:41–5PubMedCrossRef
11.
Boer-Meisel ME, te Velde ER, Habbema JDF, Kardaun JWPF. Predicting the pregnancy outcome in patients treated for hydrosalpinx: a prospective study. Fertil Steril 1986;45:23–9PubMed
12.
Mage G, Pouly JL, de Joliniere JB, Chabrand S, Riouallon A, Bruhat MA. A preoperative classification to predict the intrauterine and ectopic pregnancy rates after distal tubal microsurgery. Fertil Steril 1986;46:807–10PubMed
13.
Oh ST. Tubal patency and conception rates with three methods of laparoscopic terminal neosalpingostomy. J Am Assoc Gynecol Laparos 1996;3:519–23CrossRef
14.
Milingos SD, Kallipolitis GK, Loutradis DC, Liapi AG, Hassan EA, Mavrommatis CG. et al. Laparoscopic treatment of hydrosalpinx: factors affecting pregnancy rate. J Am Assoc Gynecol Laparos 2000;7:355–61
15.
Marana R, Rizzi M, Muzii L, Catalano GF, Caruana P, Mancuso S. Correlation between the American Fertility Society classifications of adnexal adhesions and distal tubal occlusion, salpingoscopy, and reproductive outcome in tubal surgery. Fertil Steril 1995;64:924–9PubMed
16.
Canis M, Mage G, Pouly JL, Manhes H, Wattiez A, Bruhat MA. Laparoscopic distal tuboplasty: report of 87 cases and a 4-year experience. Fertil Steril 1991;56:616–21PubMed
17.
te Velde ER, Boer-Meisel ME, Meisner J, Schoemaker J, Habbema JDF. The significance of preoperative hysterosalpingogram and laparoscopy for predicting the pregnancy outcome in patients with bilateral hydrosalpinx. Eur J Obstet Gynecol Reprod Biol 1989;31:33–45PubMedCrossRef
18.
Schlaff WD, Hassiakos DK, Damewood MD, Rock JA. Neosalpingostomy for distal tubal obstruction: prognostic factors and impact of surgical technique. Fertil Steril 1990;54:984–90PubMed
19.
Donnez J, Casanas-Roux F. Prognostic factors of fimbrial microsurgery. Fertil Steril 1986;46:200–4PubMed
20.
Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization embryo transfer. Fertil Steril 1998;70:492–9PubMedCrossRef
21.
Wainer R, Camus E, Camier B, Martin C, Vasseur C, Merlet F. Does hydrosalpinx reduce the pregnancy rate after in vitro fertilization? Fertil Steril 1997;68:1022–6PubMedCrossRef
22.
The practice committee of the American Society for Reproductive Medicine. Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril 2004;82:S117–9
23.
Gomel V. Salpingo-ovariolysis by laparoscopy in infertility. Fertil Steril 1983;40:607–11PubMed
24.
Vasquez G, Boeckx W, Brosens I. Prospective study of tubal mucosal lesions and fertility in hydrosalpinges. Hum Reprod 1995;10:1075–8PubMed
25.
Chong AP. Pregnancy outcome in neosalpingostomy by the cuff vs. Bruhat technique using the carbon dioxide laser. J Gynecol Surg 1991;7:207–10PubMedCrossRef
26.
Dubuisson JB, de Joliniere JB, Aubriot FX, Darai E, Foulot H, Mandelbrot L. Terminal tuboplasties by laparoscopy: 65 consecutive cases. Fertil Steril 1990;54:401–3PubMed
27.
Kitchin JD, Nunley WC, Bateman BG. Surgical management of distal tubal occlusion. Am J Obstet Gynecol 1986;155:524–9PubMed
28.
Kosasa TS, Hale RW. Treatment of hydrosalpinx using a single incision eversion procedure. Int J Fertil 1988;33:319–23PubMed
29.
Kodaman PH, Arici A, Seli E. Evidence based diagnosis and management of tubal factor infertility. Curr Opin Obstet Gynecol 2004;16:221–9PubMedCrossRef
Metadaten
Titel
Recurrence of hydrosalpinges after cuff neosalpingostomy in a poor prognosis population
verfasst von
Aykut Bayrak
Djana Harp
Peyman Saadat
Eliran Mor
Richard J. Paulson
Publikationsdatum
01.06.2006
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 6/2006
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-006-9050-4

Weitere Artikel der Ausgabe 6/2006

Journal of Assisted Reproduction and Genetics 6/2006 Zur Ausgabe

Assisted Reproduction

Human papilloma virus DNA exposure and embryo survival is stage-specific

Assisted Reproduction

Influence of the Preimplantation Embryo Development (Ped) Gene on Embryonic Platelet-Activating Factor (PAF) Levels

Assisted Reproduction

Subclinical Pregnancy Losses Among Women Undergoing In-Vitro Fertilization With ICSI

Assisted Reproduction

Is a lower dose of cetrorelix acetate effective for prevention of LH surge during controlled ovarian hyperstimulation?

Assisted Reproduction

Prenatal Diagnosis of Meckel–Gruber Syndrome in a Pregnancy Obtained With ICSI

Original Paper

Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

23.04.2024 Medikamente in Schwangerschaft und Stillzeit Nachrichten

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise